肝肿瘤微波消融术后血红蛋白尿的危险因素
本研究纳入2011年1月至2017年4月期间因肝肿瘤接受超声引导下经皮微波消融(MWA)的2829例患者,其中149例术后出现血红蛋白尿。单因素分析显示组织病理学、肝硬化、MWA体积、MWA能量和MWA持续时间是显著危险因素;多因素分析和ROC曲线确定MWA能量、持续时间和体积为预测因素。经肾脏保护、充分水化、碱化尿液和利尿等药物治疗后,1例进展为急性肾损伤(AKI),其余患者临床结局良好。
要点
- MWA能量、持续时间和体积是肝肿瘤MWA术后血红蛋白尿的独立预测因素。
- 血红蛋白尿患者经肾脏保护、水化、碱化尿液和利尿治疗后多预后良好。
- 149例(2829例中)出现血红蛋白尿,其中1例进展为急性肾损伤(AKI)。
核心结论
- 血红蛋白尿是肝肿瘤MWA术后可控的副作用,与高MWA能量、长MWA持续时间和大的MWA体积相关;经正确治疗通常对肾功能影响小。
研究设计与样本
- 回顾性研究,纳入2011年1月至2017年4月期间接受超声引导下经皮MWA的肝肿瘤患者2829例,评估19项危险因素,采用二元logistic回归和ROC曲线分析。
诊断标准与关键数值
- 单因素分析显示组织病理学、肝硬化、MWA体积、MWA能量和MWA持续时间是显著危险因素;多因素分析和ROC曲线确定MWA能量、持续时间和体积为预测因素。
临床应用与阅片要点
- 对接受MWA的肝肿瘤患者,应关注MWA能量、持续时间和体积等参数;术后出现血红蛋白尿时,可采用肾脏保护、充分水化、碱化尿液和利尿等药物治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To explore the risk factors predicting haemoglobinuria after ultrasound-guided percutaneous microwave ablation (MWA) of liver tumours and discuss the treatments and outcomes.
MATERIALS AND METHODS: The present study comprised 2,829 patients admitted for liver tumours treated with MWA from Jan 2011 to April 2017. Ethics committee approval was waived and informed consent for treatment procedures were obtained from the patients. Haemoglobinuria after MWA was found in 149 patients. The influence of 19 risk factors was assessed. Binary logistic regression and receiver operating characteristic (ROC) curve analysis were used for statistical analysis. The treatments and outcomes of patients with haemoglobinuria were summarised.
RESULTS: By univariate analysis, histopathology, liver cirrhosis, MWA volume, MWA energy, and MWA duration were significant risk factors. By multivariate analysis and ROC curve, MWA energy, duration, and volume were identified as predictors of haemoglobinuria after MWA. Drug treatments including kidney protection, adequate hydration, alkalisation of urine, and diuresis were administrated to the patients with haemoglobinuria. One patient progressed to acute kidney injury (AKI) while others had good clinical outcomes.
CONCLUSION: Haemoglobinuria is a controllable side effect after MWA of liver tumours, which is related to high MWA energy, long MWA duration, and great MWA volume. It usually caused few side effects on renal function with correct treatment.
引用
- Li D, Yu J, Han Z, et al. Risk factors of haemoglobinuria after microwave ablation of liver tumours. Clin Radiol. 2018. PMID: 30029835. doi:10.1016/j.crad.2018.06.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。